rfhg_6743.1

Basic information about the TSS

---

TSS ID: rfhg_6743.1 Species: human Chr: chr1		Start: 51577169 End: 51577169 Strand: +
Source datasets	EPD
Protocol	TSS_database
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2164978,EH38E1347030)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000371714.5:10 AK128043:10 GeneID: 114883 HGNC/MGI_ID: HGNC:16386 UniProt_ID: Q96SU4 Nearer transcript ids and distances:

Gene_name: oxysterol binding protein like 9 Gene_symbol: OSBPL9 Gene_synonyms: Gene_source: HGNC:16386

TATA-Box annotation

---

Distance to TSS:	6562
Nearest PromoterID:	NR_161259
Entrez ID:	441884
Nearest Unigene:
Nearest Refseq:	NR_161259
Nearest Ensembl:
Gene Name:	oxysterol binding protein like 9
Gene Alias:	-
Gene Type:	pseudo
CpG%:	0.000000
GC%:	0.000000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@OSBPL9 p2@OSBPL9 p3@OSBPL9
Sample		p1@OSBPL9	p2@OSBPL9	p3@OSBPL9
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	37.99	15.58	1.17
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	35.00	17.80	0.61
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	40.90	15.43	0.58
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	32.85	13.93	0.42
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	37.57	18.22	0.67
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	31.98	10.47	0.39
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	52.07	20.05	0.65
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	44.08	16.71	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	40.82	20.52	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	78.25	21.45	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	81.25	20.21	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	87.41	23.58	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	25.79	20.15	2.58
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	26.91	20.90	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	23.71	18.44	1.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	24.14	19.87	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	26.43	15.29	0.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	23.20	14.34	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	14.93	17.06	2.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	20.61	14.59	1.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	20.58	20.32	1.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	23.99	14.16	1.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	23.91	20.55	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	22.33	20.14	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	21.16	17.54	1.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	22.47	17.41	1.58
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	23.08	9.34	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	24.05	23.58	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	14.54	16.15	1.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	22.08	17.73	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	20.10	18.42	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	18.76	13.29	1.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	20.68	15.41	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	32.49	18.47	1.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	17.76	14.96	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	19.35	14.75	1.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	21.87	17.58	1.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	22.97	14.31	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	24.85	17.56	1.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	24.01	17.52	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	24.23	14.35	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	27.52	17.27	1.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	19.61	12.86	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	18.53	15.38	1.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	22.09	15.26	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	22.10	12.80	1.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	24.71	13.91	1.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	26.23	17.88	0.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	20.83	13.64	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	21.23	9.10	1.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	27.46	16.19	1.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	26.91	12.45	0.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	125.93	55.97	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	23.07	12.77	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	19.22	10.60	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	111.58	24.33	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	48.22	23.42	0.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	15.56	13.94	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	20.88	13.81	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	48.09	26.40	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	19.04	11.28	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	18.51	10.65	2.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	59.71	24.68	1.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	38.05	19.37	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	18.52	11.37	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	16.68	17.04	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	129.31	96.98	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	244.82	71.08	7.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	9.26	17.55	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	10.41	8.93	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	14.54	16.42	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	19.54	15.90	1.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	17.01	12.06	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	14.06	15.59	0.92
Adipocyte - breast, donor1	11376-118A8	100.73	8.08	1.27
Adipocyte - breast, donor2	11327-117E4	46.68	11.71	2.41
Adipocyte - omental, donor1	11473-119C6	80.41	9.29	1.65
Adipocyte - omental, donor2	11474-119C7	56.06	9.72	2.24
Adipocyte - omental, donor3	11475-119C8	55.60	5.02	1.34
Adipocyte - perirenal, donor1	11476-119C9	47.85	10.21	3.19
Adipocyte - subcutaneous, donor1	11259-116F8	9.90	2.20	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	18.52	3.61	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	13.38	0.00	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	33.44	6.85	1.96
Adipocyte differentiation, day04, donor2	13022-139D7	21.62	7.46	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	29.55	5.85	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	28.80	2.94	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	35.79	5.39	0.24
Adipocyte differentiation, day08, donor2	13023-139D8	29.37	6.13	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	20.79	4.80	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	21.70	5.56	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	18.72	5.41	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	23.86	4.77	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	23.56	1.96	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	20.70	3.35	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	4.64	7.07	0.66
Alveolar Epithelial Cells, donor2	11590-120G6	2.15	1.79	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	1.20	2.40	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	14.21	10.43	0.90
Amniotic Epithelial Cells, donor2	11613-122A2	1.67	6.69	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	7.60	6.57	0.21
Anulus Pulposus Cell, donor1	11248-116E6	35.59	7.32	0.57
Anulus Pulposus Cell, donor2	11463-119B5	15.67	4.16	0.73
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	25.61	4.94	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	25.18	3.91	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	19.26	2.14	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	24.21	3.59	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	24.03	1.26	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	11.88	1.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	15.59	2.92	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	21.36	3.88	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	13.66	2.97	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	19.96	2.26	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	20.32	5.08	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	12.54	1.25	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	27.84	3.13	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	10.92	2.73	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	17.04	3.77	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	16.61	3.21	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	21.92	3.59	0.38
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	21.12	2.67	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	19.51	3.90	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	18.08	2.99	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	13.21	2.40	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	21.24	3.54	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	19.73	3.43	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	12.58	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	27.18	3.40	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	24.28	4.17	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	13.33	2.42	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	21.09	2.85	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	17.53	1.71	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	13.16	2.06	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	10.79	1.41	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	16.08	2.89	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	8.56	1.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	17.55	2.34	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	21.08	2.41	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	13.07	1.19	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	21.36	1.02	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	18.34	4.58	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	12.71	1.27	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	18.12	3.02	1.29
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	21.38	3.81	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	15.66	2.61	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	19.84	0.94	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	16.44	3.22	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	18.53	2.32	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	27.46	4.23	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	18.87	2.79	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	13.84	1.20	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	18.22	3.64	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	23.68	4.60	0.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	12.75	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	16.78	2.29	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	19.41	2.89	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	15.30	3.06	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	25.81	2.87	1.43
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	15.08	2.66	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	4.58	3.05	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	19.94	2.22	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	16.68	3.18	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	9.45	1.82	0.36
Astrocyte - cerebellum, donor1	11500-119F6	7.12	7.37	0.25
Astrocyte - cerebellum, donor2	11580-120F5	5.65	3.77	0.00
Astrocyte - cerebellum, donor3	11661-122F5	5.87	1.89	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	37.65	22.31	3.14
Astrocyte - cerebral cortex, donor2	11316-117D2	19.25	21.19	1.78
Astrocyte - cerebral cortex, donor3	11392-118C6	24.46	26.85	2.83
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	26.95	55.51	8.95
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	22.43	54.50	9.90
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	23.56	56.56	7.97
Basophils, donor1	12241-129G9	36.88	1.31	0.00
Basophils, donor2	12242-129H1	77.57	10.82	0.72
Basophils, donor3	12243-129H2	43.81	2.20	0.29
Bronchial Epithelial Cell, donor1	11511-119G8	3.45	2.59	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	0.91	2.29	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	50.21	21.52	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	6.28	6.90	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	5.82	5.82	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	7.37	10.59	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	21.23	13.68	0.36
Burkitt's lymphoma cell line:DAUDI	10422-106C8	24.94	89.66	7.83
Burkitt's lymphoma cell line:RAJI	10476-106I8	26.32	68.47	3.73
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	52.44	23.34	2.56
CD133+ stem cells - cord blood derived, pool1	12223-129E9	51.71	20.68	0.00
CD14+ Monocytes, donor1	11224-116B9	89.61	3.38	0.00
CD14+ Monocytes, donor2	11305-117B9	84.82	2.78	0.19
CD14+ Monocytes, donor3	11381-118B4	65.42	1.98	0.66
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	69.63	11.04	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	55.72	12.51	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	65.09	8.55	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	59.84	1.88	0.29
CD14+ monocytes - mock treated, donor2	11873-125C1	50.99	0.91	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	44.54	0.95	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	44.03	0.84	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	32.29	1.38	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	45.12	0.50	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	41.90	0.78	0.39
CD14+ monocytes - treated with BCG, donor2	11870-125B7	38.81	1.78	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	68.55	1.52	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	64.62	0.70	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	69.17	1.58	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	69.89	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	55.48	0.74	0.30
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	41.11	0.60	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	48.72	1.67	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	59.94	2.75	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	42.53	0.45	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	48.01	0.87	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	52.45	1.34	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	49.02	1.57	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	55.97	1.68	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	47.76	1.29	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	31.35	2.11	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	38.61	1.75	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	46.21	1.22	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	40.88	1.12	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	72.42	1.29	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	58.15	3.28	2.05
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	39.64	1.16	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	48.02	1.86	0.46
CD14+CD16+ Monocytes, donor1	11789-124B7	47.73	0.22	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	56.59	0.46	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	44.19	0.65	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	102.62	0.47	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	81.21	0.17	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	129.55	0.45	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	42.87	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	53.35	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	44.64	0.21	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	54.87	20.32	4.06
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	52.20	33.22	2.03
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	39.35	38.32	2.07
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	76.22	35.18	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	56.82	39.13	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	43.52	18.95	2.11
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	42.36	29.02	2.35
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	68.55	34.28	5.27
CD19+ B Cells, donor1	11544-120B5	60.82	9.86	0.00
CD19+ B Cells, donor2	11624-122B4	60.21	10.16	0.00
CD19+ B Cells, donor3	11705-123B4	58.56	13.13	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	67.48	23.03	2.02
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	33.56	19.97	1.20
CD34+ Progenitors, donor1	11545-120B6	85.34	20.08	1.00
CD34+ Progenitors, donor2	11625-122B5	119.67	16.29	1.69
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	45.84	33.82	2.63
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	48.25	39.01	4.96
CD4+ T Cells, donor1	11225-116C1	134.61	20.71	1.79
CD4+ T Cells, donor2	11306-117C1	82.67	12.25	0.61
CD4+ T Cells, donor3	11382-118B5	58.25	13.42	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	48.24	19.65	0.77
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	35.94	22.24	1.57
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	39.38	17.25	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	81.07	15.17	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	80.77	14.05	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	49.44	3.30	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	36.42	14.74	1.16
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	22.20	8.64	1.02
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	19.18	9.99	0.48
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	56.49	7.17	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	60.44	12.58	1.05
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	69.08	11.00	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	64.09	22.35	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	26.39	11.84	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	28.40	13.03	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	87.83	16.59	0.27
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	106.65	20.37	1.07
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	73.52	10.76	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	40.98	24.48	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	30.98	15.60	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	39.93	18.07	0.42
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	53.59	12.13	1.01
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	48.52	13.86	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	69.73	18.74	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	60.37	23.75	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	62.78	25.85	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	62.81	13.96	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	85.02	29.63	1.38
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	89.81	31.41	1.72
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	80.08	26.18	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	71.27	28.29	1.79
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	58.17	24.93	6.92
CD8+ T Cells, donor1	11226-116C2	107.06	20.95	0.98
CD8+ T Cells, donor2	11307-117C2	70.58	14.27	1.88
CD8+ T Cells, donor3	11383-118B6	87.61	18.68	1.51
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	13.30	6.65	0.92
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	11.98	11.02	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	14.50	8.75	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	22.82	7.51	0.60
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	9.84	9.36	0.96
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	11.82	6.82	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	17.17	10.86	0.65
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	17.63	12.11	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	15.24	9.85	0.94
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	15.70	11.47	0.60
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	15.11	8.72	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	13.85	11.99	1.07
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	16.63	7.88	1.75
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	16.40	15.48	2.28
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	11.19	10.44	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	14.05	11.52	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	13.81	9.21	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	12.49	7.54	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	22.18	11.09	0.63
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	19.68	8.30	0.62
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	16.67	11.54	0.64
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	20.65	8.41	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	18.13	11.43	0.79
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	12.86	9.83	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	63.43	14.45	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	42.67	9.09	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	55.10	12.02	1.00
Cardiac Myocyte, donor1	11525-119I4	38.38	12.79	0.00
Cardiac Myocyte, donor2	11605-120I3	10.87	15.32	0.49
Cardiac Myocyte, donor3	11686-122I3	27.89	21.05	1.58
Chondrocyte - de diff, donor1	11261-116G1	26.69	0.69	0.00
Chondrocyte - de diff, donor2	11338-117F6	23.45	1.07	0.00
Chondrocyte - de diff, donor3	11410-118E6	19.23	0.46	0.11
Chondrocyte - re diff, donor2	11339-117F7	44.76	3.58	0.00
Chondrocyte - re diff, donor3	11411-118E7	17.79	3.64	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	41.89	36.49	1.61
Ciliary Epithelial Cells, donor2	11323-117D9	25.44	29.07	1.28
Ciliary Epithelial Cells, donor3	11399-118D4	25.40	26.73	3.54
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	66.39	12.84	1.65
Corneal Epithelial Cells, donor1	11526-119I5	3.95	3.07	0.00
Corneal Epithelial Cells, donor2	11606-120I4	4.55	6.83	0.00
Corneal Epithelial Cells, donor3	11687-122I4	5.11	2.81	0.51
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	19.98	23.94	1.49
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	23.02	29.96	0.95
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	13.80	31.06	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	14.69	17.93	1.08
Dendritic Cells - plasmacytoid, donor1	11228-116C4	56.71	34.51	4.44
Dendritic Cells - plasmacytoid, donor2	11309-117C4	52.23	31.99	3.92
Dendritic Cells - plasmacytoid, donor3	11385-118B8	58.56	43.07	5.32
Endothelial Cells - Aortic, donor0	11207-116A1	18.34	13.51	2.33
Endothelial Cells - Aortic, donor1	11263-116G3	9.98	10.56	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	13.29	13.01	1.41
Endothelial Cells - Aortic, donor3	11412-118E8	10.62	7.86	0.39
Endothelial Cells - Artery, donor1	11264-116G4	9.60	7.85	1.16
Endothelial Cells - Artery, donor2	11341-117F9	13.41	13.65	1.18
Endothelial Cells - Artery, donor3	11413-118E9	14.20	11.40	0.70
Endothelial Cells - Lymphatic, donor1	11236-116D3	27.48	22.17	2.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	40.47	38.03	1.83
Endothelial Cells - Lymphatic, donor3	11393-118C7	42.57	27.91	1.69
Endothelial Cells - Microvascular, donor1	11265-116G5	17.83	5.05	1.49
Endothelial Cells - Microvascular, donor2	11342-117G1	13.02	7.81	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	11.63	2.98	0.43
Endothelial Cells - Thoracic, donor1	11266-116G6	25.61	17.21	1.60
Endothelial Cells - Thoracic, donor2	11343-117G2	6.81	8.39	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	46.34	52.43	3.60
Endothelial Cells - Umbilical vein, donor2	11324-117E1	20.21	30.20	3.69
Endothelial Cells - Umbilical vein, donor3	11400-118D5	24.91	29.80	3.18
Endothelial Cells - Vein, donor1	11267-116G7	7.96	4.55	1.14
Endothelial Cells - Vein, donor2	11344-117G3	9.78	13.27	0.00
Endothelial Cells - Vein, donor3	11416-118F3	10.21	13.97	1.26
Eosinophils, donor1	12244-129H3	45.74	0.00	15.25
Eosinophils, donor2	12245-129H4	275.59	14.85	0.00
Eosinophils, donor3	12246-129H5	238.98	7.13	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	2.20	3.18	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	4.16	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	46.80	18.47	2.87
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	10.51	3.50	0.11
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	19.72	8.02	0.98
Fibroblast - Aortic Adventitial, donor1	11245-116E3	42.33	18.31	2.43
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	81.20	6.55	0.14
Fibroblast - Aortic Adventitial, donor2	11326-117E3	21.62	4.32	0.53
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	77.99	8.43	0.79
Fibroblast - Aortic Adventitial, donor3	11401-118D6	27.90	12.29	1.66
Fibroblast - Cardiac, donor1	11268-116G8	11.34	12.25	0.91
Fibroblast - Cardiac, donor2	11345-117G4	18.95	15.92	1.52
Fibroblast - Cardiac, donor3	11417-118F4	11.51	9.46	1.73
Fibroblast - Cardiac, donor4	11452-119A3	40.31	14.85	3.03
Fibroblast - Cardiac, donor5	11456-119A7	26.90	23.35	2.54
Fibroblast - Cardiac, donor6	11460-119B2	25.47	29.11	2.43
Fibroblast - Choroid Plexus, donor1	11492-119E7	11.52	11.93	0.94
Fibroblast - Choroid Plexus, donor2	11572-120E6	27.18	26.32	1.73
Fibroblast - Choroid Plexus, donor3	11653-122E6	27.83	27.83	4.39
Fibroblast - Conjunctival, donor1	11531-120A1	4.61	3.69	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	39.18	5.09	0.34
Fibroblast - Dermal, donor1	11269-116G9	8.22	8.69	0.94
Fibroblast - Dermal, donor2	11346-117G5	10.38	12.74	0.94
Fibroblast - Dermal, donor3	11418-118F5	13.90	3.26	0.12
Fibroblast - Dermal, donor4	11450-119A1	23.97	10.17	0.79
Fibroblast - Dermal, donor5	11454-119A5	20.76	12.04	0.70
Fibroblast - Dermal, donor6	11458-119A9	28.26	13.81	1.62
Fibroblast - Gingival, donor1	11237-116D4	24.15	5.00	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	44.54	11.00	1.31
Fibroblast - Gingival, donor2	11318-117D4	19.90	15.55	0.66
Fibroblast - Gingival, donor3	11394-118C8	18.66	2.90	0.58
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	27.01	3.12	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	11.98	3.88	0.18
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	20.27	9.04	0.62
Fibroblast - Gingival, donor6 (control)	11922-125H5	20.96	3.65	0.27
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	7.76	8.47	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	22.52	8.34	0.44
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	31.91	9.95	0.41
Fibroblast - Gingival, donor8 (control)	11926-125H9	23.15	8.34	0.77
Fibroblast - Gingival, donor9 (control)	11927-125I1	28.61	2.20	0.15
Fibroblast - Lung, donor1	11270-116H1	12.23	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	29.84	8.95	0.00
Fibroblast - Lung, donor3	11419-118F6	13.93	7.18	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	4.17	4.17	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	2.80	2.80	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	1.96	1.96	0.00
Fibroblast - Mammary, donor1	11540-120B1	6.50	11.77	1.62
Fibroblast - Mammary, donor2	11620-122A9	0.00	3.99	0.00
Fibroblast - Mammary, donor3	11701-123A9	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	29.68	24.63	1.36
Fibroblast - Periodontal Ligament, donor2	11319-117D5	23.66	16.84	0.76
Fibroblast - Periodontal Ligament, donor3	11395-118C9	32.74	10.71	0.92
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	16.03	6.87	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	15.12	8.37	1.35
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	13.45	4.06	0.58
Fibroblast - Pulmonary Artery, donor1	11250-116E8	29.07	24.21	1.99
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	4.47	4.88	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	2.67	3.34	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	18.58	4.35	0.79
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	63.90	1.79	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	28.77	1.78	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	31.53	3.74	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	39.41	0.30	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	33.46	1.51	0.22
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	67.57	4.56	0.00
Fibroblast - skin normal, donor1	11553-120C5	32.65	5.91	1.15
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	79.20	0.60	0.00
Fibroblast - skin normal, donor2	11561-120D4	43.80	1.81	0.10
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	81.30	3.32	0.91
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	42.00	2.40	0.25
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	52.48	5.47	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	50.25	5.58	0.99
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	34.83	8.63	1.28
Fibroblast - skin walker warburg, donor1	11554-120C6	25.81	14.00	0.84
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	30.74	4.70	0.47
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	288.08	44.32	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	42.71	6.10	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	41.43	23.75	1.04
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	32.01	23.16	1.56
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	31.94	13.54	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	19.90	22.20	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	26.80	19.78	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	31.95	27.96	1.71
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	29.78	35.57	1.10
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	50.92	24.20	1.60
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	22.98	30.12	1.19
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	26.43	33.04	1.06
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	32.61	30.01	3.91
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	33.61	37.59	3.10
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	33.35	30.24	1.98
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	36.20	34.36	2.71
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	25.25	26.06	0.81
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	41.01	25.03	1.98
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	60.77	27.96	1.38
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	42.29	26.84	0.20
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	37.88	25.78	0.46
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	59.17	29.52	0.75
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	45.46	25.14	0.66
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	32.21	27.48	0.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	34.97	28.29	1.11
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	30.83	27.70	0.45
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	30.04	33.47	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	34.78	31.38	2.04
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	46.46	49.83	1.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	62.43	55.15	2.91
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	49.01	48.67	2.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	37.73	32.64	2.32
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	47.09	51.58	1.83
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	41.65	52.27	2.04
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	34.45	28.88	1.86
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	37.93	37.12	2.19
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	29.18	35.35	1.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	31.74	27.55	2.20
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	50.06	39.23	3.94
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	25.45	33.23	1.46
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	36.88	18.60	0.96
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	31.55	30.23	2.94
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	27.68	32.11	2.21
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	28.89	28.89	1.22
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	37.84	29.90	2.93
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	29.86	34.47	2.20
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	34.51	23.00	1.40
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	29.54	28.05	2.59
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	28.08	31.55	1.07
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	23.41	33.05	1.38
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	26.04	31.61	3.76
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	28.73	40.93	3.52
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	34.66	32.81	2.77
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	27.41	30.27	2.41
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	48.60	45.62	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	24.80	26.65	1.06
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	19.97	20.38	1.61
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	119.96	74.98	4.32
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	51.36	58.13	4.38
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	34.05	35.13	2.47
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	40.92	46.03	2.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	11.27	32.23	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	16.11	25.71	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	23.06	36.90	1.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	27.22	29.70	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	31.72	22.05	2.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	35.30	16.04	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	22.60	24.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	23.11	28.97	1.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	35.00	39.53	1.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	16.66	29.99	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	26.57	29.92	1.12
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	28.76	32.36	1.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	25.17	31.88	1.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	37.21	42.94	1.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	26.15	32.95	1.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	25.06	41.76	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	28.63	43.53	2.29
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	19.83	26.64	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	30.49	54.21	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	35.21	49.70	2.90
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	33.60	39.58	2.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	21.07	73.76	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	31.14	39.98	1.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	32.27	38.14	2.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	36.12	40.80	2.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	40.45	44.69	1.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	44.16	40.74	2.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	44.73	42.24	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	36.33	36.80	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	26.55	40.43	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	33.57	42.73	2.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	47.86	35.50	3.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	51.31	47.36	1.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	35.41	46.04	3.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	37.34	28.01	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	50.47	47.84	1.76
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	26.28	39.84	2.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	20.89	24.47	2.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	32.51	27.17	2.91
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	10.27	10.27	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	13.31	14.55	2.91
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	12.37	2.25	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	21.57	5.07	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	12.11	2.51	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	25.88	18.10	1.39
Hep-2 cells mock treated, biol_rep2	11899-125E9	24.65	17.56	2.19
Hep-2 cells mock treated, biol_rep3	11900-125F1	24.57	18.20	1.37
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	24.70	16.72	1.75
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	21.49	17.19	2.79
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	23.90	17.01	1.29
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	30.39	15.07	1.62
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	24.87	15.95	1.72
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	18.58	15.38	0.96
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	3.92	6.72	1.68
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	1.73	1.30	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	15.86	10.58	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	4.23	5.29	1.41
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	7.99	7.27	1.45
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	12.94	18.53	2.10
Hepatocyte, donor1	11523-119I2	65.37	49.63	4.84
Hepatocyte, donor2	11603-120I1	36.63	46.33	3.23
Hepatocyte, donor3	11684-122I1	34.97	32.52	9.20
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	41.12	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	38.28	49.64	2.80
Iris Pigment Epithelial Cells, donor1	11530-119I9	18.80	21.13	2.33
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	19.10	31.84	12.74
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	26.70	26.70	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	54.17	27.08	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	30.46	22.15	1.38
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	12.51	15.02	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	11.87	11.87	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	28.19	28.19	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	13.71	18.28	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	42.23	24.36	3.25
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	36.68	23.34	3.33
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	32.68	21.78	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	30.44	21.18	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	26.61	26.61	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	31.43	5.24	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	40.94	22.68	4.41
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	24.75	18.56	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	73.17	14.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	33.59	25.84	5.81
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	38.64	11.27	1.61
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	47.79	11.95	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	40.74	21.19	2.44
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	31.49	15.11	0.84
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	34.56	24.11	5.63
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	26.78	20.31	1.85
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	26.91	25.49	2.36
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	22.67	14.51	3.63
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	14.74	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	38.74	31.21	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	34.30	22.87	2.54
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	16.43	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	36.35	22.32	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	12.76	34.63	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	31.61	63.22	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	39.99	14.28	3.57
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	43.14	23.23	3.32
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	41.70	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	28.09	33.34	4.94
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	29.85	19.32	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	40.86	15.72	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	25.73	23.64	3.48
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	26.56	13.28	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	16.21	22.69	6.48
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	20.05	20.93	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	33.75	13.50	4.50
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	17.42	6.97	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	23.47	12.80	2.13
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	19.40	27.71	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	22.80	25.65	2.85
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	11.97	26.69	1.84
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	18.15	12.10	3.03
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	37.25	37.25	6.21
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	19.03	16.92	1.06
Keratinocyte - epidermal, donor1	11272-116H3	22.85	15.26	0.41
Keratinocyte - epidermal, donor2	11349-117G8	7.61	0.59	0.00
Keratinocyte - epidermal, donor3	11421-118F8	30.29	0.28	0.00
Keratinocyte - oral, donor1	11251-116E9	45.07	38.03	1.25
Keratocytes, donor1	11527-119I6	6.53	2.41	0.00
Keratocytes, donor2	11607-120I5	1.17	0.00	0.00
Keratocytes, donor3	11688-122I5	13.04	4.74	0.40
Krukenberg tumor cell line:HSKTC	10687-109F3	19.78	24.18	2.20
Lens Epithelial Cells, donor1	11529-119I8	21.57	10.79	2.16
Lens Epithelial Cells, donor2	11609-120I7	32.29	33.79	1.96
Lens Epithelial Cells, donor3	11690-122I7	18.87	36.33	4.24
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	21.11	10.55	1.66
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	12.28	5.86	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	22.20	15.74	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	17.74	5.38	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	8.51	4.73	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	8.84	4.53	0.65
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	18.88	9.44	1.23
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	6.83	3.03	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	11.82	6.90	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	22.15	10.28	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	17.45	7.56	0.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	5.00	3.52	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	21.25	12.19	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	11.69	8.11	0.72
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	9.89	6.04	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	19.09	7.08	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	8.11	4.05	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	9.15	6.22	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	17.11	6.58	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	7.91	4.10	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	7.22	4.23	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	20.85	9.21	0.97
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	18.04	5.12	0.81
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	17.86	7.42	1.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	14.52	5.70	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	19.47	9.21	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	9.02	7.52	0.45
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	18.57	6.88	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	16.18	5.46	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	8.27	3.61	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	22.78	13.08	1.45
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	11.58	4.96	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	8.42	4.83	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	34.06	13.33	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	14.33	6.67	0.99
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	7.84	3.16	0.27
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	22.84	10.94	0.96
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	24.96	5.78	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	20.85	8.82	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	23.82	9.60	1.42
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	8.73	1.45	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	5.45	2.96	0.31
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	17.19	10.03	0.72
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	19.27	4.90	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	4.94	4.47	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	21.04	9.53	0.12
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	8.45	2.31	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	8.65	4.18	0.60
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	20.39	9.06	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	12.27	6.14	1.53
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	16.33	3.71	1.48
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	24.12	5.92	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	21.10	4.22	1.41
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	14.01	3.74	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	15.46	4.12	1.03
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	22.60	5.95	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	21.26	6.11	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	23.85	3.49	0.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	22.06	4.95	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	31.16	10.03	0.81
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	19.00	3.08	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	21.52	9.17	1.41
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	19.32	6.00	1.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	23.43	4.58	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	26.41	9.87	1.07
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	26.83	6.24	0.76
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	22.09	3.68	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	22.83	8.97	1.63
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	27.28	6.46	1.46
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	28.31	7.57	0.56
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	23.70	7.21	2.06
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	24.39	9.00	1.45
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	19.73	6.28	0.90
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	23.79	8.85	1.11
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	19.80	5.66	1.41
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	21.02	7.01	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	19.57	10.36	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	25.71	6.52	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	19.25	3.40	1.13
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	20.51	7.38	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	23.50	5.87	0.90
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	17.95	5.75	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	22.41	5.23	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	23.41	4.09	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	22.83	5.17	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	13.70	3.43	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	16.66	3.66	1.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	15.69	2.41	1.21
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	16.35	5.69	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	23.03	5.84	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	18.25	4.29	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	14.81	4.04	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	23.71	4.44	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	30.24	5.81	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	8.46	5.29	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	34.01	4.00	1.60
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	13.81	5.81	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	23.76	7.67	1.53
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	19.24	4.44	0.99
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	16.00	5.65	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	23.63	4.53	1.51
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	24.78	4.96	1.35
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	12.05	6.88	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	27.61	4.90	0.89
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	21.90	5.08	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	19.13	9.90	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	18.68	4.15	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	18.82	8.31	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	17.89	6.15	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	15.02	4.86	3.97
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	19.67	5.79	1.54
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	16.71	5.06	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	18.26	6.25	0.96
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	26.64	7.55	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	27.34	1.82	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	13.83	5.53	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	22.42	6.84	0.76
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	27.37	6.71	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	19.95	6.65	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	19.96	6.34	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	17.06	7.46	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	28.16	5.17	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	23.14	7.71	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	16.27	4.24	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	24.40	6.81	2.84
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	27.87	6.24	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	15.66	1.57	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	23.38	10.86	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	15.33	2.32	0.93
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	16.73	7.36	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	17.11	4.28	1.07
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	18.18	7.68	2.02
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	12.85	6.42	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	19.56	2.67	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	22.79	7.41	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	14.57	5.37	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	17.51	3.28	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	14.25	7.57	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	15.08	7.54	1.56
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	21.88	5.30	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	16.63	6.24	0.00
Macrophage - monocyte derived, donor1	11232-116C8	46.95	19.14	1.37
Macrophage - monocyte derived, donor2	11313-117C8	18.90	25.87	1.47
Macrophage - monocyte derived, donor3	11389-118C3	21.37	19.14	2.10
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	22.30	14.34	1.06
Mallassez-derived cells, donor2	11929-125I3	41.83	28.84	1.27
Mallassez-derived cells, donor3	11930-125I4	36.00	25.02	0.69
Mammary Epithelial Cell, donor1	11273-116H4	47.93	23.42	1.79
Mammary Epithelial Cell, donor2	11350-117G9	30.11	27.80	0.29
Mammary Epithelial Cell, donor3	11422-118F9	5.24	6.73	0.25
Mast cell - stimulated, donor1	11487-119E2	105.08	60.34	8.81
Mast cell, donor1	11563-120D6	64.67	35.69	3.57
Mast cell, donor2	11565-120D8	69.84	63.00	13.67
Mast cell, donor3	11566-120D9	74.07	77.89	13.73
Mast cell, donor4	11567-120E1	71.45	61.16	10.64
Mast cell, expanded and stimulated, donor5	11940-126A5	60.21	47.24	2.99
Mast cell, expanded and stimulated, donor8	11942-126A7	50.20	30.35	0.58
Mast cell, expanded, donor5	11939-126A4	54.49	41.30	2.41
Mast cell, expanded, donor8	11941-126A6	71.97	30.13	2.18
Melanocyte - dark, donor1	11502-119F8	28.56	19.60	0.90
Melanocyte - dark, donor2	11582-120F7	10.73	20.42	2.77
Melanocyte - dark, donor3	11663-122F7	36.58	66.21	7.53
Melanocyte - light, donor1	11274-116H5	13.16	11.99	0.71
Melanocyte - light, donor2	11351-117H1	13.65	23.20	1.36
Melanocyte - light, donor3	11423-118G1	8.67	2.60	4.34
Melanocyte, donor1 (MC+1)	12641-134G4	25.93	36.13	3.75
Melanocyte, donor2 (MC+2)	12739-135I3	22.05	26.36	3.50
Melanocyte, donor3 (MC+3)	12837-137B2	50.36	64.82	10.98
Meningeal Cells, donor1	11493-119E8	10.79	10.92	0.62
Meningeal Cells, donor2	11573-120E7	7.92	9.68	0.00
Meningeal Cells, donor3	11654-122E7	37.08	25.18	0.65
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	30.23	19.96	2.57
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	25.26	15.50	1.61
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	5.26	7.88	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	2.62	1.31	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	8.61	12.20	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	30.49	24.35	2.96
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	21.11	15.08	2.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	4.18	4.18	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	5.11	2.19	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	4.50	2.25	0.41
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	32.69	11.77	0.83
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	5.95	4.46	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	36.18	30.13	3.03
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	5.04	4.45	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	2.34	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	6.40	4.48	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	23.75	26.58	1.77
Mesenchymal stem cells - hepatic, donor0	11218-116B3	28.77	29.71	4.38
Mesenchymal stem cells - umbilical, donor0	11214-116A8	13.79	15.97	1.45
Mesothelial Cells, donor1	11247-116E5	38.45	25.72	2.12
Mesothelial Cells, donor2	12156-128G5	18.02	22.52	3.00
Mesothelial Cells, donor3	11402-118D7	17.13	15.18	1.45
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	12.15	54.01	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	27.83	30.54	3.45
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	20.32	42.11	3.24
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	10.37	6.91	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	31.30	25.73	0.93
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	18.88	27.17	2.49
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	16.21	18.53	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	34.04	22.27	1.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	24.20	30.72	4.19
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	19.47	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	25.00	23.17	1.63
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	18.61	32.47	1.98
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	8.55	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	11.50	18.58	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	23.94	23.94	1.52
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	5.26	9.21	3.95
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	22.07	18.46	1.06
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	4.60	21.18	1.84
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	12.22	23.84	0.60
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	5.03	16.77	5.03
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	33.95	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	15.56	17.81	2.26
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	14.97	34.46	3.09
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	2.76	13.82	1.66
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	17.27	18.65	3.91
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	19.35	31.13	3.16
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	12.23	22.01	3.47
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	20.17	23.17	1.29
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	14.45	37.12	3.11
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	30.96	10.32
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	9.20	24.09	2.63
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	7.60	34.47	1.01
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	0.00	51.37	3.31
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	14.40	35.60	3.81
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	12.65	49.11	4.71
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	6.54	34.89	7.63
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	12.01	27.39	2.88
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	11.61	45.63	6.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	2.74	41.14	10.97
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	9.01	43.55	4.51
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	53.89	26.95
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	4.08	16.31	8.15
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	5.26	51.24	5.26
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	1.10	50.77	6.62
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	3.84	43.55	4.48
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	9.67	57.02	8.68
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	7.65	49.41	11.83
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	8.84	72.93	8.84
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	11.97	55.04	11.97
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	4.81	52.08	7.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	5.68	42.61	12.43
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	12.62	60.32	8.98
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	7.90	47.80	9.98
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	2.33	37.30	5.83
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	5.73	50.68	7.24
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	9.60	45.50	7.93
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	43.31	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	8.31	43.41	9.24
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	13.66	54.64	8.54
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	11.61	38.14	6.63
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	12.96	43.28	6.22
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	11.58	57.91	7.72
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	6.99	34.30	3.81
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	8.81	49.91	8.81
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	21.85	41.61	3.59
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	9.04	28.96	5.09
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	11.15	37.90	4.78
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	17.91	64.79	12.38
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	4.93	36.40	6.07
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	17.05	47.16	4.26
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	16.22	60.22	6.64
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	7.82	17.60	1.96
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	19.99	30.28	3.23
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	19.03	45.84	4.90
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	24.32	27.61	0.82
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	20.55	29.18	2.38
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	15.07	15.07	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	10.69	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	28.91	5.91	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	11.57	11.57	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	30.84	10.28	0.59
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	17.70	7.45	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	27.79	4.88	1.13
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	16.51	9.06	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	28.05	13.91	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	11.79	4.42	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	15.76	7.33	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	10.89	9.33	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	28.86	10.69	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	15.46	3.86	3.86
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	17.17	5.05	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	9.70	10.12	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	14.98	10.90	1.36
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	6.99	10.17	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	12.15	5.67	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	4.53	7.55	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	57.10	5.71	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	78.30	39.15	6.52
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	9.50	38.02	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	37.65	12.55	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	34.04	19.60	3.02
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	38.67	20.90	3.66
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	8.01	5.34	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	5.01	2.92	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	32.32	5.13	0.57
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	15.96	7.98	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	0.68	0.68	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	73.51	9.19	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	5.02	2.09	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	12.55	3.95	0.46
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	9.19	2.43	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	21.44	3.57	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	122.48	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	15.88	0.99	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	17.32	3.52	0.54
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	12.47	1.59	0.45
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	9.63	3.10	0.33
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	26.06	3.28	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	7.96	1.06	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	9.60	1.20	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	53.82	5.25	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	7.64	1.79	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	20.28	2.82	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	10.55	0.70	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	10.11	0.46	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	13.82	3.21	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	52.77	4.83	2.07
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	118.84	15.17	5.06
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	15.37	3.12	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	8.89	1.69	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	20.89	0.24	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	13.31	2.58	1.29
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	189.58	9.03	9.03
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	11.00	1.67	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	11.27	2.71	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	11.11	1.19	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	6.50	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	14.38	0.76	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	10.43	3.58	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	10.46	2.18	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	17.19	3.17	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	8.82	0.88	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	14.63	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	15.87	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	6.89	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	29.34	2.12	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	21.00	6.85	0.88
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	8.81	0.68	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	97.08	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	21.34	1.83	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	11.02	0.63	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	10.29	1.82	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	11.87	2.37	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	61.22	5.67	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	121.39	5.06	0.00
Myoblast, donor1	11241-116D8	20.62	5.34	0.37
Myoblast, donor2	11322-117D8	21.10	5.18	0.58
Myoblast, donor3	11398-118D3	34.14	6.39	1.35
NK T cell leukemia cell line:KHYG-1	10777-110G3	18.24	17.51	2.04
Natural Killer Cells, donor1	11230-116C6	104.25	14.15	1.23
Natural Killer Cells, donor2	11311-117C6	71.77	7.54	0.30
Natural Killer Cells, donor3	11387-118C1	78.41	12.15	1.47
Neural stem cells, donor1	11275-116H6	63.51	24.68	1.09
Neural stem cells, donor2	11352-117H2	51.99	23.11	0.00
Neurons, donor1	11494-119E9	52.34	1.14	1.14
Neurons, donor2	11574-120E8	46.23	9.47	0.44
Neurons, donor3	11655-122E8	39.46	4.11	0.82
Neutrophils, donor1	11233-116C9	247.78	6.50	1.86
Neutrophils, donor2	11314-117C9	234.81	2.90	5.80
Neutrophils, donor3	11390-118C4	402.55	50.70	8.55
Nucleus Pulposus Cell, donor1	11252-116F1	47.73	9.14	1.31
Nucleus Pulposus Cell, donor2	11409-118E5	20.51	6.84	0.98
Nucleus Pulposus Cell, donor3	11462-119B4	14.24	7.42	0.20
Olfactory epithelial cells, donor1	11933-125I7	33.45	18.72	3.03
Olfactory epithelial cells, donor2	11934-125I8	38.65	13.61	2.32
Olfactory epithelial cells, donor3	11935-125I9	36.09	15.44	1.70
Olfactory epithelial cells, donor4	11936-126A1	31.65	10.52	0.39
Oligodendrocyte - precursors, donor1	11496-119F2	34.30	34.91	1.20
Osteoblast - differentiated, donor1	11276-116H7	18.08	3.40	0.21
Osteoblast - differentiated, donor2	11353-117H3	4.57	2.29	1.14
Osteoblast - differentiated, donor3	11425-118G3	11.17	1.24	0.00
Osteoblast, donor1	11277-116H8	19.15	7.04	0.78
Osteoblast, donor2	11354-117H4	24.58	26.69	1.40
Osteoblast, donor3	11426-118G4	14.93	13.86	0.71
Pancreatic stromal cells, donor1	11249-116E7	37.57	9.94	0.67
Pericytes, donor1	11491-119E6	4.34	2.56	0.45
Pericytes, donor2	11571-120E5	3.40	2.49	0.23
Pericytes, donor3	11652-122E5	4.07	4.48	0.20
Perineurial Cells, donor1	11499-119F5	34.47	15.71	1.47
Perineurial Cells, donor2	11579-120F4	26.68	29.44	3.40
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	112.52	12.43	0.64
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	71.01	3.67	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	54.87	6.99	0.78
Placental Epithelial Cells, donor1	11278-116H9	17.46	7.41	0.48
Placental Epithelial Cells, donor2	11355-117H5	15.52	13.31	0.00
Placental Epithelial Cells, donor3	11427-118G5	12.76	11.78	0.79
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	18.67	18.67	4.75
Preadipocyte - breast, donor1	11467-119B9	65.84	16.13	1.69
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	106.25	18.80	4.83
Preadipocyte - breast, donor2	11328-117E5	34.22	16.89	3.83
Preadipocyte - omental, donor1	11468-119C1	49.66	14.81	1.60
Preadipocyte - omental, donor2	11329-117E6	54.56	29.24	3.49
Preadipocyte - omental, donor3	11403-118D8	31.23	19.20	3.58
Preadipocyte - perirenal, donor1	11469-119C2	25.59	2.95	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	8.91	7.68	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	19.30	12.93	1.59
Preadipocyte - subcutaneous, donor3	11428-118G6	18.39	7.83	1.02
Preadipocyte - visceral, donor1	11280-116I2	32.51	12.57	0.75
Preadipocyte - visceral, donor2	11357-117H7	19.79	6.90	0.46
Preadipocyte - visceral, donor3	11429-118G7	16.72	11.91	0.42
Prostate Epithelial Cells (polarized), donor1	11253-116F2	27.91	42.39	2.56
Prostate Epithelial Cells, donor2	11331-117E8	18.82	13.54	0.27
Prostate Epithelial Cells, donor3	11404-118D9	18.92	8.08	0.55
Prostate Stromal Cells, donor1	11254-116F3	30.18	9.91	1.59
Prostate Stromal Cells, donor2	11332-117E9	21.52	5.20	0.54
Prostate Stromal Cells, donor3	11405-118E1	25.96	7.40	1.46
Renal Cortical Epithelial Cells, donor1	11516-119H4	9.12	5.47	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	56.42	22.46	0.55
Renal Epithelial Cells, donor1	11517-119H5	2.54	6.09	0.51
Renal Epithelial Cells, donor2	11597-120H4	7.82	2.85	0.00
Renal Epithelial Cells, donor3	11678-122H4	48.59	28.27	0.74
Renal Glomerular Endothelial Cells, donor1	11514-119H2	1.36	4.09	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	5.66	6.60	0.67
Renal Glomerular Endothelial Cells, donor3	11675-122H1	20.87	18.65	2.66
Renal Glomerular Endothelial Cells, donor4	11783-124B1	2.00	2.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	8.14	5.94	0.22
Renal Mesangial Cells, donor2	11598-120H5	5.02	6.27	0.00
Renal Mesangial Cells, donor3	11679-122H5	2.77	1.39	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	15.30	6.71	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	10.12	3.37	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	6.36	5.21	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	35.78	42.26	3.11
Retinal Pigment Epithelial Cells, donor1	11528-119I7	8.81	6.82	1.14
Retinal Pigment Epithelial Cells, donor2	11608-120I6	3.09	5.15	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	29.36	27.85	0.50
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	103.17	31.27	4.81
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	75.94	33.06	2.68
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	204.74	20.36	1.10
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	168.80	51.62	3.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	119.10	56.17	8.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	75.87	27.51	4.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	132.06	48.07	5.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	149.97	49.12	7.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	87.53	33.56	4.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	114.87	33.75	3.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	95.15	33.54	5.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	82.90	34.34	3.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	93.36	51.07	6.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	93.68	40.89	6.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	83.17	34.45	4.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	97.36	27.22	4.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	92.91	36.90	5.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	83.01	30.84	5.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	143.19	50.55	1.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	79.23	41.54	7.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	86.93	33.68	5.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	105.60	27.50	5.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	92.27	36.74	5.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	75.68	33.92	3.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	95.87	32.30	2.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	84.24	37.56	5.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	82.16	30.04	5.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	101.01	27.13	4.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	114.16	33.73	4.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	91.87	30.56	6.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	98.92	32.27	3.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	101.60	30.48	6.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	118.79	32.30	3.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	74.78	25.27	5.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	91.38	31.22	5.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	80.21	33.04	5.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	77.89	27.18	4.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	112.62	30.60	2.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	72.97	29.49	4.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	94.56	25.94	2.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	91.86	30.68	3.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	93.36	29.30	5.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	75.43	29.05	3.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	106.47	35.81	4.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	77.38	28.81	4.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	104.80	37.29	5.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	102.65	40.68	4.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	94.33	27.25	3.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	90.36	18.74	3.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	88.61	36.72	4.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	311.48	74.23	5.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	94.91	36.51	4.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	96.45	38.28	4.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	91.38	21.04	2.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	112.63	42.24	4.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	122.33	33.65	3.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	90.71	26.25	4.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	111.78	40.27	1.80
Schwann Cells, donor1	11498-119F4	4.51	4.89	0.19
Schwann Cells, donor2	11578-120F3	13.61	13.61	0.00
Schwann Cells, donor3	11659-122F3	19.72	18.84	3.51
Sebocyte, donor1	11220-116B5	16.98	15.34	0.55
Sebocyte, donor2	11301-117B5	12.87	10.57	0.46
Sebocyte, donor3	11378-118B1	7.42	3.92	0.00
Sertoli Cells, donor1	11255-116F4	57.98	13.25	3.31
Sertoli Cells, donor2	11333-117F1	33.89	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	23.31	3.52	0.18
Skeletal Muscle Cells, donor2	11358-117H8	7.95	0.72	0.00
Skeletal Muscle Cells, donor3	11430-118G8	4.18	3.34	0.00
Skeletal Muscle Cells, donor4	11451-119A2	22.94	21.52	2.36
Skeletal Muscle Cells, donor5	11455-119A6	20.66	17.39	2.23
Skeletal Muscle Cells, donor6	11459-119B1	28.93	14.77	0.77
Skeletal Muscle Satellite Cells, donor1	11240-116D7	59.85	42.59	4.91
Skeletal Muscle Satellite Cells, donor2	11321-117D7	24.11	25.68	2.85
Skeletal Muscle Satellite Cells, donor3	11397-118D2	22.32	22.12	1.49
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	21.99	4.80	0.51
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	5.07	2.17	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	9.08	3.44	0.14
Skin - palm, donor1	10286-104F7	67.15	2.69	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	4.61	14.42	0.29
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	102.24	49.89	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	7.66	12.98	0.52
Small Airway Epithelial Cells, donor1	11256-116F5	21.69	20.43	0.83
Small Airway Epithelial Cells, donor2	11334-117F2	11.96	14.63	0.70
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	80.56	39.12	1.69
Small Airway Epithelial Cells, donor3	11406-118E2	9.82	15.07	0.67
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	15.12	5.86	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	44.91	3.56	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	13.52	7.64	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	24.53	9.06	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	10.63	3.54	0.79
Smooth Muscle Cells - Aortic, donor3	11432-118H1	13.91	6.95	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	55.04	2.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	11.44	7.05	0.27
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	12.63	7.98	1.55
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	21.51	13.70	0.90
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	33.21	30.61	2.93
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	25.69	25.40	3.54
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	13.24	21.92	2.99
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	2.28	0.98	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	19.79	5.18	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	14.90	4.04	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	36.72	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	9.54	6.20	1.43
Smooth Muscle Cells - Colonic, donor1	11239-116D6	23.60	29.35	2.95
Smooth Muscle Cells - Colonic, donor2	11320-117D6	14.64	27.55	2.58
Smooth Muscle Cells - Colonic, donor3	11396-118D1	16.06	21.83	3.78
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	9.13	4.49	0.31
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	6.47	7.55	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	7.47	17.93	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	2.05	4.10	0.68
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	43.98	37.62	3.14
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	28.88	3.12	0.20
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	22.07	6.83	0.91
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	6.04	3.62	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	24.37	20.13	1.32
Smooth Muscle Cells - Prostate, donor1	11257-116F6	33.96	16.25	1.20
Smooth Muscle Cells - Prostate, donor2	11335-117F3	16.65	10.14	0.75
Smooth Muscle Cells - Prostate, donor3	11465-119B7	25.87	9.13	0.51
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	25.18	6.03	0.30
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	6.00	1.50	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	71.07	3.88	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	13.02	5.58	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	8.08	7.07	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	8.78	4.70	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	0.88	1.18	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	25.74	22.33	1.83
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	17.75	8.88	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	14.39	9.93	0.58
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	11.22	8.67	1.53
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	6.96	6.77	0.38
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	29.77	24.18	3.49
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	24.55	30.33	3.44
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	1.43	3.33	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	11.50	8.81	1.22
Smooth Muscle Cells - Uterine, donor1	11258-116F7	23.64	9.72	1.99
Smooth Muscle Cells - Uterine, donor3	11466-119B8	30.43	10.83	0.59
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	19.05	5.25	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	15.60	7.93	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	42.77	1.49	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	29.47	1.80	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	15.05	7.10	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	25.21	16.94	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	22.09	5.08	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	25.56	3.59	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	17.97	5.43	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	25.67	9.63	0.46
Synoviocyte, donor1	11291-117A4	38.04	6.56	0.84
Synoviocyte, donor2	11368-117I9	25.98	1.51	0.00
Synoviocyte, donor3	11440-118H9	22.79	1.34	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	1.79	7.50	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	3.96	1.98	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	3.24	5.33	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	14.55	8.24	0.36
Tracheal Epithelial Cells, donor2	11369-118A1	6.57	5.41	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	7.44	4.58	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	99.40	29.03	5.41
Urethra, donor2	10319-105A4	91.72	8.99	0.00
Urothelial Cells, donor1	11520-119H8	2.66	2.39	0.27
Urothelial Cells, donor2	11600-120H7	2.40	2.80	0.40
Urothelial Cells, donor3	11681-122H7	3.21	1.83	0.00
Urothelial cells, donor0	11216-116B1	48.15	27.86	2.45
Whole blood (ribopure), donor090309, donation1	12179-129A1	80.97	19.58	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	85.78	18.58	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	40.39	6.85	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	60.26	13.43	1.38
Whole blood (ribopure), donor090325, donation2	12177-128I8	59.26	12.20	1.16
Whole blood (ribopure), donor090612, donation1	12182-129A4	57.27	12.49	3.12
Whole blood (ribopure), donor090612, donation2	12183-129A5	80.77	14.68	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	31.95	8.22	0.91
Wilms' tumor cell line:G-401	10809-111A8	42.07	31.58	4.07
Wilms' tumor cell line:HFWT	10597-108E3	12.32	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	62.01	13.69	2.23
achilles tendon, donor2	10292-104G4	68.20	10.33	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	25.75	73.17	8.41
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	47.13	56.42	3.48
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	58.64	59.47	5.58
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	41.91	29.12	1.09
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	33.73	23.33	1.12
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	55.20	30.66	1.90
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	60.70	35.12	3.54
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	19.39	53.32	3.53
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	39.20	26.54	1.63
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	31.84	27.96	3.49
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	17.85	25.94	0.37
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	78.01	27.30	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	45.08	42.29	4.88
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	29.26	39.61	0.52
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	18.12	34.78	1.17
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	18.59	13.01	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	30.43	27.14	1.23
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	6.14	30.08	0.92
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	36.70	49.07	2.56
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	31.85	43.67	2.73
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	25.03	54.40	2.41
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	22.50	16.93	2.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	21.68	17.68	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	16.72	57.60	3.72
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	81.36	113.75	11.68
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	43.61	35.76	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	24.37	39.36	3.75
adenocarcinoma cell line:IM95m	10796-110I4	24.73	19.78	1.41
adipose tissue, adult, pool1	10010-101C1	111.38	5.43	0.62
adipose, donor1	10184-103D4	70.96	56.30	1.76
adipose, donor2	10185-103D5	18.25	10.14	0.00
adipose, donor3	10186-103D6	75.42	18.79	0.54
adipose, donor4	10187-103D7	203.69	28.60	2.60
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	20.52	7.26	0.00
adrenal gland, adult, pool1	10081-102A9	10.91	3.64	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	37.09	69.24	17.08
alveolar cell carcinoma cell line:SW 1573	10708-109H6	35.37	11.08	0.71
amniotic membrane cells, donor1	12235-129G3	62.14	11.13	0.93
amniotic membrane cells, donor2	12236-129G4	100.42	28.40	2.37
amniotic membrane cells, donor3	12237-129G5	72.18	11.78	0.88
amygdala - adult, donor10196	10167-103B5	49.80	0.00	0.00
amygdala, adult, donor10252	10151-102I7	54.14	4.46	0.20
amygdala, newborn, donor10223	10360-105E9	30.34	2.26	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	53.61	22.28	1.91
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	10.81	20.08	0.88
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	33.40	32.40	3.01
aorta, adult, pool1	10052-101G7	68.45	6.67	0.20
appendix, adult	10189-103D9	57.83	29.89	2.33
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	37.49	31.30	1.03
artery, adult	10190-103E1	105.98	1.36	0.00
astrocytoma cell line:TM-31	10425-106D2	87.79	54.90	5.79
b cell line:RPMI1788	10427-106D4	22.45	84.91	16.21
basal cell carcinoma cell line:TE 354.T	10702-109G9	24.69	8.88	0.83
bile duct carcinoma cell line:HuCCT1	10432-106D9	39.39	22.72	1.29
bile duct carcinoma cell line:TFK-1	10496-107C1	61.60	22.43	2.18
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	11.18	3.91	0.00
bladder, adult, pool1	10011-101C2	89.30	2.93	0.33
blood, adult, pool1	10053-101G8	31.00	4.43	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	35.97	0.00	0.00
bone marrow, adult	10192-103E3	75.58	16.20	0.00
brain, adult, donor1	10084-102B3	28.70	4.10	0.00
brain, adult, pool1	10012-101C3	51.22	1.78	0.22
brain, fetal, pool1	10085-102B4	37.40	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	97.13	0.00	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	36.45	0.00	0.00
breast, adult, donor1	10080-102A8	52.40	3.79	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	17.28	10.29	0.51
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	42.67	25.67	1.24
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	38.68	12.43	0.92
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	15.01	3.15	0.00
carcinoid cell line:NCI-H1770	10703-109H1	62.06	39.49	0.47
carcinoid cell line:NCI-H727	10735-110B6	26.58	21.22	1.75
carcinoid cell line:SK-PN-DW	10719-109I8	34.22	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	57.49	8.25	0.27
caudate nucleus - adult, donor10196	10177-103C6	72.53	6.91	0.00
caudate nucleus, adult, donor10252	10164-103B2	58.56	6.69	0.50
caudate nucleus, adult, donor10258	10379-105H1	32.09	8.41	0.76
caudate nucleus, newborn, donor10223	10354-105E3	34.43	5.13	0.00
cerebellum - adult, donor10196	10173-103C2	168.97	8.74	0.00
cerebellum, adult, donor10252	10166-103B4	191.73	1.49	0.21
cerebellum, adult, pool1	10083-102B2	44.15	2.76	0.00
cerebellum, newborn, donor10223	10357-105E6	221.69	4.98	0.00
cerebral meninges, adult	10188-103D8	44.12	4.29	1.01
cerebrospinal fluid, donor2	10294-104G6	52.62	6.58	0.00
cervical cancer cell line:D98-AH2	10552-107I3	35.66	32.35	1.15
cervical cancer cell line:ME-180	10553-107I4	35.96	9.94	0.66
cervix, adult, pool1	10013-101C4	118.43	10.08	1.05
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	74.55	20.62	2.09
chondrosarcoma cell line:SW 1353	10700-109G7	15.68	15.68	0.00
choriocarcinoma cell line:BeWo	10423-106C9	326.72	0.00	0.00
choriocarcinoma cell line:SCH	10785-110H2	204.90	0.00	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	150.85	0.00	0.00
chorionic membrane cells, donor1	12238-129G6	50.15	11.97	0.85
chorionic membrane cells, donor2	12239-129G7	33.01	18.10	0.60
chorionic membrane cells, donor3	12240-129G8	70.88	18.13	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	25.25	25.25	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	16.71	36.31	2.50
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	34.63	48.78	3.38
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	53.41	87.83	5.91
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	50.07	102.31	6.53
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	60.27	85.92	7.13
chronic myelogenous leukemia cell line:K562	10454-106G4	54.18	111.60	7.07
chronic myelogenous leukemia cell line:KU812	10409-106B4	56.03	45.09	4.69
clear cell carcinoma cell line:JHOC-5	10638-108I8	65.60	31.09	0.69
clear cell carcinoma cell line:TEN	10636-108I6	34.70	23.08	1.39
colon carcinoma cell line:CACO-2	10513-107D9	25.81	36.06	1.46
colon carcinoma cell line:COLO-320	10420-106C6	60.43	67.65	2.66
colon, adult, donor1	10082-102B1	20.23	4.76	0.00
colon, adult, pool1	10014-101C5	48.76	8.58	0.59
colon, fetal, donor1	10070-101I7	41.41	3.09	0.62
common myeloid progenitor CMP, donor1	12130-128D6	187.92	32.08	4.58
common myeloid progenitor CMP, donor2	12134-128E1	25.04	25.04	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	79.89	14.45	1.27
cord blood derived cell line:COBL-a 24h infection	10453-106G3	35.77	21.13	1.66
cord blood derived cell line:COBL-a untreated	10449-106F8	37.51	23.97	1.41
corpus callosum, adult, pool1	10042-101F6	145.28	4.20	0.44
cruciate ligament, donor2	10295-104G7	106.17	3.24	0.00
diaphragm, fetal, donor1	10069-101I6	39.33	1.61	0.00
diencephalon, adult	10193-103E4	38.40	4.56	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	19.52	41.10	3.44
ductal cell carcinoma cell line:KLM-1	10438-106E6	80.78	29.49	1.28
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	54.16	32.74	6.26
ductus deferens, adult	10196-103E7	58.80	17.44	1.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	41.77	5.76	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	66.21	24.28	2.21
dura mater, adult, donor1	10041-101F5	111.08	13.71	1.32
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	97.49	16.88	0.89
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	47.00	25.08	1.43
embryonic pancreas cell line:1B2C6	10604-108F1	14.18	14.80	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	21.19	11.20	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	17.60	15.13	0.00
embryonic pancreas cell line:2C6	10603-108E9	24.96	18.39	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	55.98	65.36	7.71
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	81.01	0.00	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	19.30	16.40	1.61
epidermoid carcinoma cell line:A431	10426-106D3	58.91	24.90	1.56
epidermoid carcinoma cell line:Ca Ski	10431-106D8	47.84	13.75	1.10
epididymis, adult	10197-103E8	100.47	11.51	0.84
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	43.64	24.31	2.66
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	8.26	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	41.67	26.60	3.41
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	45.57	31.79	3.25
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	42.24	33.94	3.58
esophagus, adult, pool1	10015-101C6	59.03	3.40	0.00
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	181.72	0.00	0.00
eye - muscle inferior rectus, donor1	10272-104E2	103.83	4.83	0.00
eye - muscle lateral, donor2	10298-104H1	58.92	0.00	0.00
eye - muscle medial, donor2	10299-104H2	59.53	1.49	0.00
eye - muscle superior, donor2	10297-104G9	57.32	2.29	0.00
eye - vitreous humor, donor1	10268-104D7	49.55	8.74	4.37
eye, fetal, donor1	10054-101G9	63.56	15.76	2.03
fibrosarcoma cell line:HT-1080	10758-110E2	24.62	0.00	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	40.84	17.81	3.09
frontal lobe, adult, pool1	10040-101F4	70.09	3.19	0.09
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	73.56	48.64	3.90
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	149.96	14.81	0.46
gall bladder, adult	10198-103E9	31.87	9.66	0.72
gamma delta positive T cells, donor1	11937-126A2	44.02	22.55	2.15
gamma delta positive T cells, donor2	11938-126A3	41.83	20.92	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	52.80	17.74	1.69
gastric adenocarcinoma cell line:MKN45	10612-108F9	21.08	29.21	1.35
gastric cancer cell line:AZ521	10549-107H9	71.32	30.17	1.64
gastric cancer cell line:GSS	10560-108A2	15.56	12.81	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	54.14	17.82	1.83
giant cell carcinoma cell line:LU65	10487-107B1	23.87	9.41	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	28.97	19.03	1.12
glassy cell carcinoma cell line:HOKUG	10688-109F4	30.18	14.97	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	25.86	20.90	0.95
glioblastoma cell line:A172, tech_rep2	10444-106F3	20.36	21.35	3.09
glioblastoma cell line:T98G	10485-107A8	51.10	34.33	4.08
glioma cell line:GI-1	10413-106B8	44.22	28.70	2.64
globus pallidus - adult, donor10196	10175-103C4	90.39	1.46	0.00
globus pallidus, adult, donor10252	10161-103A8	117.17	7.57	0.73
globus pallidus, adult, donor10258	10367-105F7	121.86	2.74	0.00
globus pallidus, newborn, donor10223	10364-105F4	37.30	2.13	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	124.80	41.60	7.34
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	21.86	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	20.91	15.68	0.00
granulosa cell tumor cell line:KGN	10624-108H3	28.16	26.88	1.60
hIPS +CCl2, biol_rep1	14383-156B9	43.62	48.21	2.75
hIPS +CCl2, biol_rep2	14384-156C1	54.87	45.73	1.83
hIPS +CCl2, biol_rep3	14385-156C2	50.24	58.61	0.64
hIPS, biol_rep1	14380-156B6	24.43	30.18	0.00
hIPS, biol_rep2	14381-156B7	31.55	49.38	1.37
hIPS, biol_rep3	14382-156B8	54.07	9.93	1.10
hairy cell leukemia cell line:Mo	10712-109I1	17.82	10.92	0.29
heart - mitral valve, adult	10205-103F7	118.09	6.28	0.00
heart - pulmonic valve, adult	10206-103F8	72.17	9.41	1.05
heart - tricuspid valve, adult	10207-103F9	73.27	0.83	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	57.95	20.20	2.24
heart, adult, diseased, donor1	10051-101G6	31.51	8.09	0.43
heart, adult, pool1	10016-101C7	26.45	14.49	1.38
heart, fetal, pool1	10046-101G1	116.64	57.19	2.98
hepatic mesenchymal tumor cell line:LI90	10778-110G4	23.45	27.77	5.55
hepatoblastoma cell line:HuH-6	10633-108I3	30.92	22.59	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	30.05	74.14	17.13
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	32.41	75.25	12.74
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	28.70	72.86	15.16
hepatoma cell line:Li-7	10484-107A7	26.58	30.36	3.34
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	20.50	38.59	4.32
hippocampus - adult, donor10196	10169-103B7	58.67	1.89	0.00
hippocampus, adult, donor10252	10153-102I9	71.43	2.86	0.00
hippocampus, adult, donor10258	10374-105G5	46.31	2.99	0.00
hippocampus, newborn, donor10223	10363-105F3	17.62	1.41	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	39.67	42.72	1.83
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	20.81	21.01	1.37
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	26.91	27.42	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	24.25	28.76	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	24.01	21.95	0.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	30.37	34.16	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	46.13	28.61	0.88
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	41.36	26.07	1.72
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	38.37	29.61	1.67
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	40.25	31.02	1.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	36.16	25.55	1.45
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	43.09	37.03	4.04
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	28.01	29.58	1.41
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	36.85	22.60	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	45.38	34.04	2.62
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	27.68	23.86	0.95
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	27.91	23.98	1.31
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	37.48	32.98	2.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	29.01	11.30	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	33.65	15.01	1.36
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	34.46	18.79	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	25.15	17.15	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	24.68	17.13	0.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	26.60	20.03	1.20
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	25.49	25.86	0.74
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	31.10	23.68	1.43
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	42.87	46.55	1.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	33.10	23.59	1.06
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	23.12	25.66	0.95
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	29.66	29.96	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	32.58	16.55	1.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	37.19	17.93	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	36.17	21.55	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	33.75	17.38	1.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	24.23	13.63	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	31.59	21.51	0.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	28.01	30.91	2.42
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	35.65	35.21	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	26.83	32.20	1.95
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	22.62	30.56	0.61
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	289.54	97.60	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	50.97	36.07	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	29.01	19.70	2.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	40.17	29.67	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	40.21	20.64	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	28.64	23.87	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	46.18	38.46	2.44
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	24.51	22.90	0.81
immature langerhans cells, donor1	11904-125F5	34.87	7.26	0.97
immature langerhans cells, donor2	11905-125F6	72.08	0.00	0.00
insula, adult, pool1	10039-101F3	65.49	2.27	0.09
keratoacanthoma cell line:HKA-1	10791-110H8	22.76	4.88	0.65
kidney, adult, pool1	10017-101C8	67.29	35.24	4.51
kidney, fetal, pool1	10045-101F9	57.01	28.15	1.27
large cell lung carcinoma cell line:IA-LM	10509-107D5	96.86	65.90	2.70
large cell lung carcinoma cell line:NCI-H460	10839-111E2	13.41	4.98	0.28
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	56.70	21.65	0.92
left atrium, adult, donor1	10079-102A7	36.51	9.26	1.63
left ventricle, adult, donor1	10078-102A6	17.70	8.60	1.01
leiomyoblastoma cell line:G-402	10721-110A1	62.93	6.29	1.09
leiomyoma cell line:10964C	10569-108B2	12.57	0.00	0.00
leiomyoma cell line:15242A	10570-108B3	12.50	2.17	0.54
leiomyoma cell line:15425	10571-108B4	18.21	0.00	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	38.10	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	30.32	11.50	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	51.12	29.40	2.72
liposarcoma cell line:KMLS-1	10782-110G8	23.90	0.00	0.00
liposarcoma cell line:SW 872	10726-110A6	38.38	22.66	2.80
liver, adult, pool1	10018-101C9	58.67	73.41	13.29
liver, fetal, pool1	10086-102B5	21.64	9.41	3.76
locus coeruleus - adult, donor10196	10182-103D2	71.75	4.67	0.15
locus coeruleus, adult, donor10252	10165-103B3	75.85	5.17	0.55
locus coeruleus, adult, donor10258	10375-105G6	43.17	6.21	0.00
locus coeruleus, newborn, donor10223	10362-105F2	78.24	8.41	0.00
lung adenocarcinoma cell line:A549	10499-107C4	32.94	33.49	4.71
lung adenocarcinoma cell line:PC-14	10408-106B3	86.87	50.33	7.58
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	47.59	18.59	0.79
lung, adult, pool1	10019-101D1	86.71	23.03	2.13
lung, fetal, donor1	10068-101I5	225.47	47.66	1.43
lung, right lower lobe, adult, donor1	10075-102A3	49.49	16.95	2.29
lymph node, adult, donor1	10077-102A5	21.30	9.47	0.00
lymphangiectasia cell line:DS-1	10727-110A7	20.16	41.21	7.45
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	30.94	79.54	11.32
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	57.77	0.00	0.00
mature adipocyte, donor1	12231-129F8	83.91	0.44	0.00
mature adipocyte, donor2	12232-129F9	105.84	1.66	0.00
mature adipocyte, donor3	12233-129G1	87.48	0.47	0.00
mature adipocyte, donor4	12234-129G2	103.18	0.79	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	64.33	45.51	0.95
medial frontal gyrus - adult, donor10196	10170-103B8	56.40	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	74.85	2.76	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	36.22	2.54	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	89.14	7.25	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	77.63	1.01	0.17
medial temporal gyrus, adult, donor10252	10156-103A3	74.28	2.55	0.21
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	26.97	1.93	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	301.43	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	28.00	3.59	0.36
medulla oblongata - adult, donor10196	10174-103C3	77.88	11.68	0.00
medulla oblongata, adult, donor10252	10155-103A2	92.11	8.36	0.31
medulla oblongata, adult, pool1	10038-101F2	90.12	5.96	0.49
medulla oblongata, newborn, donor10223	10361-105F1	51.04	3.12	0.35
medulloblastoma cell line:D283 Med	10838-111E1	55.80	9.52	0.44
medulloblastoma cell line:ONS-76	10759-110E3	20.05	17.73	1.47
melanoma cell line:COLO 679	10514-107E1	32.92	43.99	2.73
melanoma cell line:G-361	10465-106H6	40.72	36.38	1.90
meningioma cell line:HKBMM	10691-109F7	20.98	15.02	1.27
merkel cell carcinoma cell line:MKL-1	10843-111E6	41.41	29.96	2.64
merkel cell carcinoma cell line:MS-1	10844-111E7	63.51	18.40	0.78
mesenchymal precursor cell - adipose, donor1	11747-123G1	24.55	7.98	1.53
mesenchymal precursor cell - adipose, donor2	11748-123G2	24.36	7.27	0.91
mesenchymal precursor cell - adipose, donor3	11749-123G3	24.43	3.73	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	22.05	2.81	0.28
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	18.29	4.43	0.39
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	23.60	0.69	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	31.07	2.06	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	24.04	3.11	0.35
mesenchymal precursor cell - cardiac, donor3	11754-123G8	25.86	8.09	0.40
mesenchymal precursor cell - cardiac, donor4	11755-123G9	26.87	12.69	2.70
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	29.45	14.80	1.42
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	23.71	7.58	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	21.31	15.77	1.94
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	23.74	3.84	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	23.48	11.23	1.02
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	21.57	11.86	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	19.55	14.07	1.03
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	16.19	5.93	0.91
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	53.70	11.75	1.26
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	23.01	14.35	2.39
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	28.01	18.12	1.31
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	37.18	13.62	1.10
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	27.76	7.73	1.72
mesenchymal stem cell line:Hu5/E18	10568-108B1	33.68	3.37	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	20.09	1.37	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	34.53	2.30	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	25.91	3.14	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	22.49	2.46	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	34.83	2.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	31.48	3.38	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	27.12	2.36	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	30.12	0.93	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	32.30	2.88	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	34.13	2.45	0.45
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	31.25	3.36	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	27.87	0.73	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	30.88	1.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	26.20	2.05	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	33.94	3.01	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	30.08	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	36.15	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	25.01	1.62	0.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	29.10	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	28.79	2.13	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	26.99	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	26.04	2.72	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	23.09	4.20	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	23.84	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	9.53	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	31.43	2.96	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	24.37	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	33.57	3.17	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	33.80	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	38.69	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	23.95	3.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	44.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	32.19	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	32.57	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	31.24	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	33.04	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	36.09	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	16.56	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	30.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	16.52	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	16.33	0.99	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	25.79	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	20.99	3.18	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	12.49	2.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	8.72	2.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	6.34	2.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	25.49	4.86	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	13.56	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	14.83	3.29	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	22.03	0.60	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	19.79	0.97	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	14.26	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	52.61	3.09	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	104.65	42.05	2.60
mesothelioma cell line:ACC-MESO-4	10494-107B8	29.42	40.31	5.56
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	12.82	21.37	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	24.66	26.82	1.85
mesothelioma cell line:Mero-25	10850-111F4	6.81	6.81	0.45
mesothelioma cell line:Mero-41	10851-111F5	52.81	37.65	3.42
mesothelioma cell line:Mero-48a	10852-111F6	47.39	52.70	3.76
mesothelioma cell line:Mero-82	10853-111F7	44.41	18.92	0.53
mesothelioma cell line:Mero-83	10854-111F8	22.98	34.73	5.62
mesothelioma cell line:Mero-84	10855-111F9	4.55	7.33	0.25
mesothelioma cell line:Mero-95	10856-111G1	26.50	28.36	2.90
mesothelioma cell line:NCI-H2052	10847-111F1	18.22	11.60	0.66
mesothelioma cell line:NCI-H226	10846-111E9	16.83	18.28	1.09
mesothelioma cell line:NCI-H2452	10848-111F2	62.52	34.85	3.59
mesothelioma cell line:NCI-H28	10845-111E8	26.72	47.08	5.09
mesothelioma cell line:No36	10857-111G2	11.74	8.48	0.65
mesothelioma cell line:ONE58	10858-111G3	48.23	16.53	0.81
migratory langerhans cells, donor1	11901-125F2	30.13	22.45	2.88
migratory langerhans cells, donor2	11902-125F3	20.64	22.71	0.73
migratory langerhans cells, donor3	11903-125F4	23.15	36.26	1.62
mixed mullerian tumor cell line:HTMMT	10689-109F5	31.99	18.94	0.98
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	37.51	19.50	1.70
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	53.44	22.34	1.84
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	19.41	12.75	1.90
myelodysplastic syndrome cell line:SKM-1	10772-110F7	34.19	36.59	3.14
myeloma cell line:PCM6	10474-106I6	41.91	34.20	3.76
myxofibrosarcoma cell line:MFH-ino	10600-108E6	15.22	13.19	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	28.24	4.32	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	23.84	7.69	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	22.80	7.57	0.15
nasal epithelial cells, donor2	12227-129F4	62.37	17.11	0.00
neuroblastoma cell line:CHP-134	10508-107D4	34.74	10.58	0.46
neuroblastoma cell line:NB-1	10539-107G8	20.21	19.46	1.12
neuroblastoma cell line:NBsusSR	10607-108F4	36.48	0.00	0.00
neuroblastoma cell line:NH-12	10555-107I6	50.69	18.45	0.75
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	52.66	0.95	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	45.14	1.27	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	41.86	22.94	1.81
neuroepithelioma cell line:SK-N-MC	10728-110A8	23.52	10.17	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	20.76	23.69	1.33
neutrophil PMN, donor1	12133-128D9	74.37	0.00	0.00
neutrophil PMN, donor2	12137-128E4	172.65	13.28	0.00
neutrophil PMN, donor3	12141-128E8	85.24	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	163.37	76.61	6.09
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	72.85	12.01	1.60
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	28.53	4.17	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	17.34	7.09	0.79
nucleus accumbens, adult, pool1	10037-101F1	72.84	4.03	0.37
occipital cortex - adult, donor10196	10172-103C1	59.75	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	95.54	3.76	0.27
occipital cortex, newborn, donor10223	10355-105E4	32.75	5.46	0.00
occipital lobe, adult, donor1	10076-102A4	37.26	1.31	0.52
occipital lobe, fetal, donor1	10073-102A1	78.10	0.86	0.00
occipital pole, adult, pool1	10036-101E9	31.14	2.05	0.08
olfactory region, adult	10195-103E6	49.29	3.82	0.00
optic nerve, donor1	10277-104E7	92.05	8.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	35.88	65.04	8.77
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	45.75	46.99	1.37
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	34.20	27.60	1.86
oral squamous cell carcinoma cell line:SAS	10544-107H4	23.79	17.44	1.16
osteoclastoma cell line:Hs 706.T	10704-109H2	30.28	1.47	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	43.91	53.26	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	35.41	0.00	0.00
ovary, adult, pool1	10020-101D2	91.02	7.16	0.79
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	23.65	19.98	2.38
pancreas, adult, donor1	10049-101G4	28.22	16.93	2.82
pancreatic carcinoma cell line:NOR-P1	10698-109G5	124.39	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	37.65	8.69	0.85
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	29.64	10.10	0.33
paracentral gyrus, adult, pool1	10035-101E8	63.70	3.02	0.09
parietal cortex, adult, donor10258	10373-105G4	74.87	2.94	0.73
parietal lobe - adult, donor10196	10171-103B9	72.42	2.82	0.00
parietal lobe, adult, donor10252	10157-103A4	82.09	2.28	0.00
parietal lobe, adult, pool1	10034-101E7	59.04	2.73	0.18
parietal lobe, fetal, donor1	10072-101I9	127.05	0.97	0.00
parietal lobe, newborn, donor10223	10356-105E5	39.26	2.62	0.00
parotid gland, adult	10199-103F1	19.12	4.93	0.00
penis, adult	10200-103F2	91.31	7.52	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	39.98	1.12	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	20.83	16.17	0.73
pineal gland - adult, donor10196	10179-103C8	130.30	5.16	0.00
pineal gland, adult, donor10252	10160-103A7	257.02	13.03	0.00
pineal gland, adult, donor10258	10377-105G8	97.82	8.15	1.25
pituitary gland - adult, donor10196	10180-103C9	96.12	10.12	1.01
pituitary gland, adult, donor10252	10162-103A9	154.27	44.30	1.56
pituitary gland, adult, donor10258	10378-105G9	46.82	28.94	0.85
placenta, adult, pool1	10021-101D3	52.57	16.45	0.86
plasma cell leukemia cell line:ARH-77	10840-111E3	30.19	36.42	4.11
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	54.47	36.11	5.76
pons, adult, pool1	10033-101E6	82.54	4.73	0.95
postcentral gyrus, adult, pool1	10032-101E5	41.58	2.44	0.26
promyelocytes/myelocytes PMC, donor1	12132-128D8	73.20	23.01	6.27
promyelocytes/myelocytes PMC, donor2	12136-128E3	22.03	5.51	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	23.47	0.00
prostate cancer cell line:DU145	10490-107B4	33.21	14.57	0.58
prostate cancer cell line:PC-3	10439-106E7	72.06	0.00	0.00
prostate, adult, pool1	10022-101D4	123.61	11.25	1.54
putamen, adult, donor10196	10176-103C5	64.45	3.54	0.00
putamen, adult, donor10252	10152-102I8	70.59	1.96	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	24.04	22.95	3.28
putamen, adult, donor10258, tech_rep2	10372-105G3	42.04	5.07	0.00
putamen, newborn, donor10223	10365-105F5	89.96	1.50	0.00
rectal cancer cell line:TT1TKB	10469-106I1	44.51	25.89	0.87
rectum, fetal, donor1	10067-101I4	68.16	5.56	2.78
renal cell carcinoma cell line:OS-RC-2	10411-106B6	73.78	20.56	0.85
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	39.76	13.25	0.41
retina, adult, pool1	10030-101E3	100.29	31.41	5.67
retinoblastoma cell line:Y79	10475-106I7	73.52	57.94	2.34
rhabdomyosarcoma cell line:KYM-1	10787-110H4	128.60	0.00	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	66.93	41.06	1.97
sacrococcigeal teratoma cell line:HTST	10695-109G2	34.10	5.30	0.00
salivary acinar cells, donor1	11771-123I7	30.75	14.24	1.78
salivary acinar cells, donor2	11772-123I8	34.70	12.12	0.28
salivary acinar cells, donor3	11773-123I9	23.83	5.30	0.00
salivary gland, adult, pool1	10093-102C3	34.32	9.72	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	59.44	22.93	1.18
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	51.96	20.45	1.41
seminal vesicle, adult	10201-103F3	75.66	10.05	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	53.69	30.85	2.19
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	21.39	12.08	0.50
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	17.06	32.11	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	19.88	21.49	1.21
signet ring carcinoma cell line:Kato III	10436-106E4	25.09	12.60	0.44
signet ring carcinoma cell line:NUGC-4	10483-107A6	10.45	26.19	1.68
skeletal muscle - soleus muscle, donor1	10282-104F3	190.81	1.42	0.71
skeletal muscle, adult, pool1	10023-101D5	120.18	1.08	0.24
skeletal muscle, fetal, donor1	10066-101I3	29.15	2.01	0.00
skin, adult, donor1	10074-102A2	27.14	0.00	0.00
skin, fetal, donor1	10065-101I2	58.70	6.31	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	15.01	14.01	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	62.10	28.37	3.78
small cell lung carcinoma cell line:DMS 144	10841-111E4	71.89	4.05	0.39
small cell lung carcinoma cell line:LK-2	10541-107H1	43.02	31.81	1.98
small cell lung carcinoma cell line:NCI-H82	10842-111E5	122.57	46.32	1.13
small cell lung carcinoma cell line:WA-hT	10562-108A4	75.18	22.88	1.09
small intestine, adult, pool1	10024-101D6	44.07	4.78	0.60
small intestine, fetal, donor1	10064-101I1	38.57	8.60	0.74
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	56.42	11.28	0.00
smooth muscle, adult, pool1	10048-101G3	77.79	0.78	0.26
somatostatinoma cell line:QGP-1	10781-110G7	37.52	17.15	2.14
spinal cord - adult, donor10196	10181-103D1	88.09	3.44	0.69
spinal cord, adult, donor10252	10159-103A6	139.18	3.94	0.79
spinal cord, adult, donor10258	10369-105F9	120.37	7.61	0.00
spinal cord, fetal, donor1	10056-101H2	70.74	1.83	0.00
spinal cord, newborn, donor10223	10359-105E8	113.43	6.43	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	20.76	15.68	1.64
spleen, adult, pool1	10025-101D7	58.15	19.49	0.44
spleen, fetal, pool1	10044-101F8	59.43	9.14	0.72
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	23.50	46.48	6.94
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	36.08	20.89	1.71
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	110.08	40.19	4.54
squamous cell carcinoma cell line:T3M-5	10616-108G4	66.85	32.45	1.56
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	55.15	43.56	2.59
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	16.94	10.17	0.85
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	20.31	30.04	1.69
stomach, fetal, donor1	10062-101H8	43.79	37.38	1.07
submaxillary gland, adult	10202-103F4	41.02	10.25	1.14
substantia nigra - adult, donor10196	10178-103C7	325.64	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	109.88	2.49	0.83
substantia nigra, adult, donor10258	10371-105G2	52.24	7.76	0.00
substantia nigra, newborn, donor10223	10358-105E7	57.23	2.83	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	39.89	0.00	0.00
temporal lobe, adult, pool1	10031-101E4	32.38	1.78	0.17
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	83.34	0.71	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	77.80	3.96	0.00
tenocyte, donor1	11763-123H8	23.39	4.19	0.00
tenocyte, donor2	11765-123I1	19.46	0.76	0.38
tenocyte, donor3	11768-123I4	16.68	1.48	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	50.48	49.97	1.53
teratocarcinoma cell line:NCR-G1	10798-110I6	24.66	28.36	1.54
teratocarcinoma cell line:PA-1	10807-111A6	33.79	40.29	2.48
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	101.68	14.60	1.14
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	66.18	20.80	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	219.00	20.07	0.76
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	78.82	15.63	0.00
testis, adult, pool1	10026-101D8	112.42	6.33	0.64
testis, adult, pool2	10096-102C6	93.37	3.61	0.45
thalamus - adult, donor10196	10168-103B6	114.81	3.31	0.00
thalamus, adult, donor10252	10154-103A1	115.65	3.13	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	27.71	9.24	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	31.95	3.46	0.00
thalamus, newborn, donor10223	10366-105F6	36.25	2.88	0.00
throat, adult	10209-103G2	69.41	8.49	0.50
throat, fetal, donor1	10061-101H7	59.42	19.20	2.44
thymic carcinoma cell line:Ty-82	10803-111A2	37.56	3.78	0.00
thymus, adult, pool1	10027-101D9	51.80	21.87	1.99
thymus, fetal, pool1	10043-101F7	87.07	23.79	1.04
thyroid carcinoma cell line:KHM-5M	10776-110G2	37.36	15.96	0.66
thyroid carcinoma cell line:TCO-1	10783-110G9	50.01	23.33	1.82
thyroid, adult, pool1	10028-101E1	63.36	47.78	4.01
thyroid, fetal, donor1	10060-101H6	36.91	20.30	2.90
tongue epidermis (fungiform papillae), donor1	10288-104F9	135.50	3.08	0.00
tongue, adult	10203-103F5	55.35	3.72	0.23
tongue, fetal, donor1	10059-101H5	32.71	5.52	0.00
tonsil, adult, pool1	10047-101G2	50.59	20.44	2.10
trachea, adult, pool1	10029-101E2	52.35	12.35	0.90
trachea, fetal, donor1	10058-101H4	60.78	7.31	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	23.38	12.40	0.71
transitional-cell carcinoma cell line:5637	10418-106C4	61.60	32.42	2.53
transitional-cell carcinoma cell line:JMSU1	10492-107B6	97.30	51.86	2.51
tridermal teratoma cell line:HGRT	10694-109G1	13.32	30.44	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	31.91	16.42	1.78
umbilical cord, fetal, donor1	10057-101H3	58.42	8.35	0.00
uterus, adult, pool1	10100-102D1	147.42	17.06	2.22
uterus, fetal, donor1	10055-101H1	63.99	5.63	1.54
vagina, adult	10204-103F6	96.28	3.23	0.00
vein, adult	10191-103E2	48.22	7.67	0.88
xeroderma pigentosum b cell line:XPL 17	10563-108A5	11.75	47.80	9.88